Blue Springs, MO, United States of America

Gary L Bafus

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gary L Bafus: Innovator in Pharmaceutical Chemistry

Introduction

Gary L Bafus is a notable inventor based in Blue Spring, MO (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pseudopolymorphs. His expertise and dedication have led to advancements that benefit the pharmaceutical industry.

Latest Patents

Gary L Bafus holds a patent for a pseudopolymorph of (−)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-one. This invention includes a method of making the pseudopolymorph, a pharmaceutical composition, and methods for utilizing the pseudopolymorph effectively. His patent represents a significant step forward in the development of pharmaceutical compounds.

Career Highlights

Throughout his career, Gary has worked with Aventis Pharmaceuticals Inc., where he has been able to apply his knowledge and skills in a practical setting. His work has contributed to the development of new pharmaceutical products that address various health issues.

Collaborations

Gary has collaborated with several professionals in his field, including Christine M Harrison-Bowman and Gary Lee Silvey. These collaborations have fostered an environment of innovation and have led to the successful development of new ideas and products.

Conclusion

In summary, Gary L Bafus is a distinguished inventor whose work in pharmaceutical chemistry has made a lasting impact. His patent and collaborations highlight his commitment to advancing the field and improving health outcomes through innovative solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…